Oncolytic viruses as anticancer agents: clinical progress and remaining challenges

Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies to overcome resistance remain of crucial importance. Oncolytic viruses offer a promising approach, with the unique ability to selectively replicate within (and to destroy) can...

Full description

Saved in:
Bibliographic Details
Main Authors: Appleton, Elizabeth (Author) , Chiocca, E Antonio (Author) , Ungerechts, Guy (Author) , Melcher, Alan (Author) , Vile, Richard (Author)
Format: Article (Journal)
Language:English
Published: 18 September 2025
In: The lancet
Year: 2025, Volume: 406, Issue: 10509, Pages: 1295-1312
ISSN:1474-547X
DOI:10.1016/S0140-6736(25)01206-1
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S0140-6736(25)01206-1
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0140673625012061
Get full text
Author Notes:Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, Alan Melcher, Richard Vile
Description
Summary:Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies to overcome resistance remain of crucial importance. Oncolytic viruses offer a promising approach, with the unique ability to selectively replicate within (and to destroy) cancer cells, remodel the immunosuppressive tumour microenvironment, and stimulate antitumour immunity. Interest in the potential of oncolytic viruses has grown steadily over the past two decades, fuelled by advances in cancer immunology and viral engineering. However, clinical translation has not kept pace, and although a plethora of promising new constructs have entered clinical testing, several barriers continue to restrict widespread clinical implementation. This Therapeutics paper highlights key milestones in oncolytic virus clinical development, discusses the challenges that remain, and, through clinical reflection, considers how future research might be streamlined to achieve meaningful benefit for patients.
Item Description:Gesehen am 05.02.2026
Physical Description:Online Resource
ISSN:1474-547X
DOI:10.1016/S0140-6736(25)01206-1